Associate Director, Drug Substance Tech Transfer Lead

Associate Director, Drug Substance Tech Transfer Lead 1. Introduction to role: Be part of history in the making. AstraZeneca is building its first biologics manufacturing campus in Singapore — a groundbreaking USD 1.5 billion investment that will serve as a global hub for innovation and excellence. This pioneering facility will deliver end-to-end Antibody-Drug Conjugate (ADC) capabilities with different manufacturing units/buildings in one campus • Small molecule- chemical API production • Large molecule- monoclonal antibody manufacturing • Conjugation • Fill-and-finish operations, including sterile filling and lyophilization • Final secondary packaging The campus will be equipped with modern digital and automation infrastructure, enabling autonomous manufacturing powered by artificial intelligence. In addition, it will be designed for carbon neutrality, embedding sustainability into every aspect of operations and setting a new benchmark for environmentally responsible biologics' manufacturing. We are looking for passionate individuals with relevant experience who thrive in dynamic environments and bring a “make-it-happen” attitude. Joining us means contributing to a project that will not only transform AstraZeneca’s global supply chain but also advance life-changing medicines for patients everywhere. If you’re ready to shape the future of biologics and be part of a once-in-a-generation project, we want you on our team 2. Introduction to role: Are you ready to lead complex biologics drug substance technology transfers that safeguard reliable supply for patients worldwide? This role puts you at the center of bringing new and established biologics to commercial scale, including antibody-drug conjugates, by translating technical knowledge into robust, compliant, and efficient manufacturing at pace across our global network. You will focus on transfers of drug substances after approval while also crafting how new products are readied for scale-up and long-term manufacturability. Working across Global CMC, manufacturing sites, quality, regulatory and external partners, you will set strategy, drive execution, and embed digital ways of working that simplify complexity and accelerate delivery. How would you use your expertise in input processes, output procedures, and conjugation to de-risk transfers and strengthen supply resilience? 3. Accountabilities: Post-Approval Tech Transfer Leadership: Lead end-to-end drug substance tech transfer activities across internal and external sites to meet Global CMC requirements, with a primary focus on post-approval biologics and ADCs, from planning through handover to commercial operations. NPI Transfer Support: Represent the manufacturing operations perspective in cross-functional planning to ensure processes are scalable, transferable, inspection-ready, and suitable for reliable commercial manufacturing. Technical Breadth Applied to Strategy: Use working knowledge of upstream, downstream, and conjugation to shape transfer strategy, conduct technical assessments, resolve issues, and implement changes across diverse biologic modalities. Site and Capability Assessment: Evaluate internal and external site capabilities for process fit, equipment readiness, capacity, and compliance to determine suitability for transfer, scale-up, and lifecycle changes. Operations Representation and Decision Influence: Embed practical manufacturing considerations into transfer strategies and execution plans by effectively representing Operations requirements with Global CMC and key stake-holders. Cross-Functional Delivery: Partner closely with Manufacturing, MS&T, Quality, Regulatory, Supply Chain, Engineering, and external partners to define and deliver transfer plans aligned to business and supply prior